The weight loss jabs, sold under the brand names Ozempic, Wegovy and Rybelsus, are set to rollout on the NHS and could improve the symptoms of heart failure in obese patients
and Rybelsus – to treat overweight people with a condition called heart failure with preserved ejection fraction .
The median age of the group was 69 and the median weight was 105.1kg – that ranges from a BMI of 31 for someone 6′ tall to 45 for someone just over 5′ tall. One group was given a once-weekly semaglutide 2.4 mg for one year while the other was given a placebo. He added: “To our knowledge, this is the first trial of a pharmacologic agent to specifically target obesity as a treatment strategy for HFpEF, and the magnitude of the benefits we observed is the largest seen with any agent in HFpEF.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
International airline to weigh passengers before boardingPassengers will be asked to step onto the scales before take-off
Lire la suite »
Mike Tyson was 'volatile and unpredictable', so Lennox Lewis weigh-in had unique twistMike Tyson caused mayhem in the build-up to his fight with Lennox Lewis in 2002. The long-awaited heavyweight super fight was initially set to take place in Las Vegas, but had to be moved after …
Lire la suite »
India’s Slowing Oil Demand Growth To Weigh On Oil PricesIndia’s slowing oil demand growth will act as a drag on oil prices despite consumption recently hitting record highs, Reuters market analyst John Kemp has said
Lire la suite »
London Zoo: Annual weigh-in sees thousands of animals on scalesAs part of London Zoo's annual weigh-in, thousands of animals are checked for health and wellbeing.
Lire la suite »